In the Department of Urology, we also have significantly expanded our clinical research efforts and offer clinical trails in all areas of genitourinary medicine and surgery. The designation of Hollings Cancer Center as a National Cancer Institute site has further increased our access to innovative and stimulating clinical trials in oncology.
Our basic science research efforts have also expanded considerably with the addition of the Brockmann Endowed Chair of Urologic Oncology which has allowed us to collaborate with other basic scientists at MUSC. These collaborations have resulted in the development of a number of novel compounds currently undergoing translation into clinical areas.
Program expansion has included a Bladder & Pelvic Health initiative for both males & females with a highly sought after fellowship program. This program is multidisciplinary and includes physicians from both Urology and Gynecology Departments. We have also developed a multi-disciplinary minimally invasive oncology surgical initiative which also includes a fellowship position. We are the only center in South Carolina offering pediatric urology and andrology services. We treat pediatric neurogenic and non-nuerogenic voiding dysfunction and also offer major reconstructive surgery in urological congenital birth defects. We are in the process of expanding our stone treatment options, both adult and pediatric, and to include a Nephrology medicine collaboration.
Our medical team focuses on providing the best possible care for individuals experiencing such illnesses as prostate cancer, bladder cancer, adrenal cancer, kidney disease and stones, testicular cancer, female and pediatric urological conditions, impotence and infertility, urinary tract infections, incontinence and bladder dysfunction by providing each patient with an individualized plan of care.